(Q36218993)

12 August 2017

Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium (English)

1 reference

genome-wide association study

12 August 2017

0 references

1 reference

Georgia Chenevix-Trench

103

Georgia Chenevix-Trench

0 references

Hoda Anton-Culver

40

Hoda Anton-Culver

0 references

Jenny Chang-Claude

17

Agnieszka Dansonka-Mieszkowska

Jenny Chang-Claude

0 references

51

Aleksandra Gentry-Maharaj

Agnieszka Dansonka-Mieszkowska

0 references

43

Aleksandra Gentry-Maharaj

0 references

Sandrina Lambrechts

14

Sandrina Lambrechts

0 references

Jolanta Kupryjanczyk

50

Jolanta Kupryjanczyk

0 references

Els Van Nieuwenhuysen

12

Els Van Nieuwenhuysen

0 references

Jolanta Lissowska

29

Jolanta Lissowska

1 reference

12 August 2017

27

Cezary Cybulski

1 reference

12 August 2017

41

Argyrios Ziogas

1 reference

Australian Ovarian Cancer Study Group

12 August 2017

104

Australian Ovarian Cancer Study Group

1 reference

12 August 2017

Yi Lu

5

0 references

Rosalind Glasspool

Rosalind Glasspool

93

0 references

Stacey J Winham

Stacey J Winham

69

0 references

Allan Jensen

Allan Jensen

74

0 references

Anna deFazio

Anna deFazio

101

0 references

Alexander Hein

Alexander Hein

8

0 references

Irene Orlow

Irene Orlow

84

0 references

Ian G. Campbell

Ian Campbell

33

0 references

Estrid Høgdall

Estrid Høgdall

73

0 references

Usha Menon

Usha Menon

44

0 references

Anna Jakubowska

Anna Jakubowska

26

0 references

Susan J. Ramus

Susan J Ramus

45

0 references

Lambertus Kiemeney

Lambertus A Kiemeney

22

0 references

Iwona K. Rzepecka

Iwona K Rzepecka

52

0 references

Joellen M Schildkraut

79

Joellen M Schildkraut

1 reference

12 August 2017

99

Paul D P Pharoah

1 reference

12 August 2017

25

Jan Lubiński

1 reference

12 August 2017

34

Diana Eccles

1 reference

12 August 2017

11

Diether Lambrechts

1 reference

12 August 2017

9

Arif B Ekici

1 reference

12 August 2017

4

Jonathan Beesley

1 reference

12 August 2017

30

Nicolas Wentzensen

1 reference

12 August 2017

28

Louise Brinton

1 reference

12 August 2017

7

Peter A Fasching

1 reference

12 August 2017

10

Matthias W Beckmann

1 reference

12 August 2017

83

Elisa V Bandera

1 reference

12 August 2017

77

Julie M Cunningham

1 reference

12 August 2017

18

Francesmary Modugno

1 reference

12 August 2017

15

Mary Anne Rossing

1 reference

12 August 2017

13

Ignace Vergote

1 reference

12 August 2017

19

Roberta B Ness

1 reference

12 August 2017

36

Alice S Whittemore

1 reference

12 August 2017

24

Jacek Gronwald

1 reference

Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe

12 August 2017

64

AGO Study Group

1 reference

12 August 2017

46

Celeste L Pearce

1 reference

12 August 2017

20

Kirsten B Moysich

1 reference

12 August 2017

81

Kathryn L Terry

1 reference

12 August 2017

42

Simon A Gayther

1 reference

12 August 2017

76

Brooke L Fridley

1 reference

12 August 2017

100

Ellen L Goode

1 reference

12 August 2017

16

Jennifer A Doherty

1 reference

12 August 2017

Douglas A Levine

21

1 reference

ORCID Public Data File 2021

Florian Heitz

Florian Heitz

58

1 reference

ORCID Public Data File 2021

Peter Hillemanns

63

Peter Hillemanns

1 reference

12 August 2017

35

Weiva Sieh

1 reference

12 August 2017

49

Anna H Wu

1 reference

12 August 2017

86

Yukie Bean

1 reference

12 August 2017

85

Tanja Pejovic

1 reference

12 August 2017

3

Siddhartha Kar

1 reference

12 August 2017

82

Daniel W Cramer

1 reference

Edwin Severin Iversen, Jr.

12 August 2017

80

Edwin S Iversen

1 reference

12 August 2017

47

Malcolm C Pike

1 reference

12 August 2017

78

Robert A Vierkant

1 reference

12 August 2017

94

Thomas Sellers

1 reference

12 August 2017

2

Jonathan P Tyrer

1 reference

12 August 2017

56

Michael E Carney

1 reference

12 August 2017

1

Sharon E Johnatty

1 reference

12 August 2017

102

Penelope M Webb

1 reference

12 August 2017

72

Zachary C Fogarty

1 reference

12 August 2017

87

Claus Høgdall

1 reference

12 August 2017

89

Ian McNeish

1 reference

12 August 2017

98

Stuart MacGregor

1 reference

12 August 2017

91

Karen Carty

1 reference

12 August 2017

59

Andreas du Bois

1 reference

12 August 2017

61

Philipp Harter

1 reference

12 August 2017

65

Beth Y Karlan

1 reference

12 August 2017

88

Lene Lundvall

1 reference

12 August 2017

23

Leon F A G Massuger

1 reference

12 August 2017

37

Valerie McGuire

1 reference

12 August 2017

68

Sandra Orsulic

1 reference

12 August 2017

38

Joseph H Rothstein

1 reference

12 August 2017

60

Ira Schwaab

1 reference

12 August 2017

31

Honglin Song

1 reference

12 August 2017

39

Rebecca Sutphen

1 reference

12 August 2017

48

Daniel O Stram

1 reference

12 August 2017

70

Madalene Earp

1 reference

12 August 2017

96

Yoke-Eng Chiew

1 reference

12 August 2017

54

Marc T Goodman

1 reference

12 August 2017

97

Andrew Berchuck

1 reference

12 August 2017

75

Susanne Kruger Kjaer

1 reference

12 August 2017

53

Beata Spiewankiewicz

1 reference

12 August 2017

62

Jacobus Pisterer

1 reference

12 August 2017

32

Valerie Rhenius

1 reference

12 August 2017

67

Jenny Lester

1 reference

12 August 2017

66

Christine Walsh

1 reference

12 August 2017

92

Nadeem Siddiqui

1 reference

12 August 2017

55

Lynne R Wilkens

1 reference

12 August 2017

57

Pamela J Thompson

1 reference

12 August 2017

Bo Gao

6

1 reference

12 August 2017

Melissa C Larson

71

1 reference

12 August 2017

James Paul

90

1 reference

12 August 2017

Catherine Kennedy

95

1 reference

12 August 2017

language of work or name

English

0 references

publication date

7 July 2015

1 reference

12 August 2017

Clinical Cancer Research

1 reference

12 August 2017

21

1 reference

12 August 2017

23

1 reference

12 August 2017

5264-5276

1 reference

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Databases for lncRNAs: a comparative evaluation of emerging tools

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

KRAS and YAP1 converge to regulate EMT and tumor survival

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

The Plexin-B family and its role in cancer progression

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Physiological and pathological roles of mitochondrial SLC25 carriers

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Structure and function of long noncoding RNAs in epigenetic regulation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Semaphorins in cancer: biological mechanisms and therapeutic approaches

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Fast and accurate genotype imputation in genome-wide association studies through pre-phasing

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Linkage-disequilibrium-based binning affects the interpretation of GWASs

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

'Genetic profiling' and ovarian cancer therapy (review).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Hippo pathway effector Yap is an ovarian cancer oncogene

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Common variants at 19p13 are associated with susceptibility to ovarian cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

METAL: fast and efficient meta-analysis of genomewide association scans

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Yorkie: the final destination of Hippo signaling.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

First-line treatment of advanced ovarian cancer: current research and perspectives.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Estimating local ancestry in admixed populations

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Principal components analysis corrects for stratification in genome-wide association studies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

The DNA sequence and biological annotation of human chromosome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Pharmacogenomics--drug disposition, drug targets, and side effects

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Pharmacogenetics and cancer therapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma cell lines

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

Pharmacogenetic perspectives gained from twin and family studies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

PARK2 orchestrates cyclins to avoid cancer.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4624261

22 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/26152742

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26152742

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26152742

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-15-0632

1 reference

12 August 2017

1 reference

12 August 2017

1 reference